News
A DAILY weight loss pill that works like Ozempic has succeeded in a major clinical trial. Patients lost an average of a stone and two pounds (7.3kg) each over 10 months. Unhealthy blood sugar ...
Ozempic is not marketed as a weight loss drug and is prescribed to those with type 2 diabetes to help manage their condition ...
Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...
Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.
When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.
Hydreight Technologies Expands GLP-1 Telehealth Suite with Launch of Liraglutide on VSDHOne Platform
As demand for GLP-1 medications surges, Hydreight’s inclusion of Liraglutide introduces a stable, patent-free, and clinically proven option—ideal for patients and providers seeking consistent ...
Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain ...
When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in ...
A cross-sectional analysis of firearm injury-related emergency department (ED) visits found that between 2018 and 2023, there was approximately one firearm injury ED visit every 30 minutes in the 10 ...
In this retrospective cohort study, tirzepatide dispensations were found to have increased significantly following approval ...
Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.
A study led by two undergraduate students at the University of Galway found that GLP-1 receptor agonists, a type of diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results